2011

New products

During 2011, the following medicines receive marketing authorization:

Anastrozex (anastrazole)

Fluvastat (fluvastatin)

Pantoprazole-Tchaikapharma (pantoprazole)

Peximir (pramipexole)

Alonzap (olanzapine)

Levor (levofloxacin)

Pipetazon (piperacillin/tazobactam)

Corabace-Co (quinapril/ hydrochlorothiazide)

Irbesso (irbesartan)

Co-Irbesso (irbesartan/hydrochlorothiazide)

Co-Hypertonic (losartan/hydrochlorothiazide)

Asprevent (montelukast)

Klacar powder for solution for infusion (clarithromycin)

Klacar XL (clarithromycin)